Oral Cancer (Squamous Cell Carcinoma of the Oral Cavity)
Persistent oral ulcer, mass, or red/white patch in a smoker or heavy drinker — biopsy any lesion not healed in 2 weeks.
Also known as: oral cancer, oral squamous cell carcinoma, oral SCC, tongue cancer, floor of mouth cancer
Overview
Malignancy arising from the mucosa of the oral cavity, including the lips, anterior two-thirds of the tongue, buccal mucosa, floor of mouth, hard palate, gingiva, and retromolar trigone. More than 90% are squamous cell carcinomas.
Epidemiology
Roughly 35,000-55,000 new oral and oropharyngeal cancer cases annually in the United States; male predominance roughly 2-3:1; median age at diagnosis approximately 63. The tongue (lateral border) and floor of the mouth are the most common subsites. Five-year survival is highly stage-dependent: greater than 80% for localized disease but less than 40% for regional or distant disease.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Oral Cancer (Squamous Cell Carcinoma of the Oral Cavity) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Chronic mucosal exposure to carcinogens drives a stepwise accumulation of mutations (TP53, CDKN2A, NOTCH1, PIK3CA) through hyperplasia, dysplasia, carcinoma in situ, and invasive carcinoma. Lymphatic spread to cervical nodes is common; the depth of invasion correlates with the risk of nodal metastasis and prognosis.
Clinical presentation
Symptoms
Non-healing oral ulcer or mass present for more than 2-3 weeks
Persistent oral pain, often dull and progressively worse
Bleeding, loose teeth, or ill-fitting dentures
Otalgia (referred pain via the auriculotemporal branch of CN V3 and via CN IX/X)
Neck mass (cervical lymphadenopathy) may be the presenting sign
Signs / physical exam
Indurated ulcer with rolled, raised, irregular borders
Red, white, or mixed (erythroleukoplakic) patch that does not wipe off
Exophytic or endophytic mass, especially on the lateral tongue or floor of mouth
Palpable firm, fixed cervical lymphadenopathy (levels I-III most often)
Reduced tongue mobility or numbness in a trigeminal distribution
Trismus suggests pterygoid invasion
Classic findings
Persistent, painless, indurated ulcer on the lateral tongue or floor of mouth in a smoker.
Differential diagnosis
Aphthous ulcer — Small, painful, round ulcer with white pseudomembrane and erythematous halo; self-limited within 2 weeks
Traumatic ulcer — History of biting or denture trauma; resolves once the trauma is removed
Herpetic ulcers — Multiple small vesicles that coalesce; keratinized mucosa primarily; recurrent; vesicular phase distinguishes
Oral lichen planus — Bilateral lace-like white striae (Wickham) or erosive plaques; chronic and symmetrical; biopsy if atypical or persistent
Leukoplakia and erythroplakia (premalignant) — Painless white or red mucosal patches that cannot be wiped off; high malignant transformation rate for erythroplakia
Necrotizing sialometaplasia — Sudden palatal ulcer in a smoker or after dental procedure; benign and self-resolving but mimics SCC histologically
Salivary gland tumor or minor salivary gland malignancy — Submucosal mass without surface ulceration; biopsy
Histologic confirmation by incisional or excisional biopsy. Staging follows AJCC 8th edition TNM system, incorporating depth of invasion and extranodal extension.
Labs
CBC, comprehensive metabolic panel, coagulation studies, type and screen for preoperative planning
HPV/p16 testing of biopsy tissue (although primarily relevant for oropharyngeal SCC, increasingly studied in oral cavity SCC)
Nutritional assessment (albumin, prealbumin) if weight loss
Imaging
Direct visualization and incisional biopsy of suspicious lesions — biopsy any lesion that has not healed within 2-3 weeks
Contrast-enhanced CT of neck — primary staging modality for tumor extent and cervical nodes
MRI of the primary site for soft tissue and perineural invasion (preferred for tongue and floor of mouth)
PET/CT for staging in advanced disease and to assess for distant metastasis or second primary
Panoramic radiograph for mandibular involvement
Examination under anesthesia with panendoscopy to evaluate for synchronous second primary lesions
Diagnostic algorithm
flowchart TD
A[Suspicious oral lesion<br/>not healed at 2-3 weeks] --> B[Incisional biopsy]
B --> C{SCC confirmed?}
C -->|No| D[Treat alternative cause<br/>re-examine 2-4 weeks]
C -->|Yes| E[CT neck + MRI<br/>+ PET/CT if advanced]
E --> F{Stage}
F -->|I-II| G[Surgery ± selective<br/>neck dissection]
F -->|III-IVA/B| H[Surgery + adjuvant<br/>(chemo)radiation]
F -->|IVC| I[Systemic therapy<br/>palliative care]
G --> J[Surveillance per NCCN]
H --> J
Diagnostic and treatment pathway for oral squamous cell carcinoma.
Treatment
First-line
Surgical resection of the primary lesion with adequate margins (typically 1 cm clinically, with frozen-section margins) — mainstay for early-stage disease
Neck dissection (selective or modified radical) for clinically positive nodes or for primary tumors with significant depth of invasion (generally greater than 3-4 mm)
Postoperative radiation therapy (with or without concurrent platinum-based chemotherapy) for advanced T-stage, positive or close margins, extranodal extension, perineural invasion, or multiple positive nodes
Second-line / adjunct
Reconstruction (radial forearm, fibula, or anterolateral thigh free flaps) for functional preservation
Speech and swallowing therapy, dental rehabilitation
Smoking and alcohol cessation counseling
Surveillance per NCCN: clinical exam every 1-3 months in year 1, every 2-6 months in year 2, every 4-8 months in years 3-5, then annually
Complications
Locoregional recurrence (highest risk in the first 2 years)
Second primary head and neck or lung malignancy
Chronic dysphagia, aspiration, xerostomia after radiation
Osteoradionecrosis of the mandible
Disfigurement and speech impairment
Cervical lymphedema
Nutritional decline and weight loss
PANCE pearls
Biopsy any oral lesion that has not healed in 2-3 weeks — do not assume aphthous ulcer.
The lateral tongue and floor of the mouth are the highest-risk subsites.
Erythroplakia carries the highest malignant transformation risk of premalignant lesions.
Refer any persistent neck mass in an adult older than 40 with risk factors for prompt workup — assume metastatic SCC until proven otherwise.
Tobacco and alcohol cessation reduces second primary risk substantially.
References
NCCN — NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (current version)
AAO-HNS — American Academy of Otolaryngology-Head and Neck Surgery resources on oral cavity malignancy
AJCC — AJCC Cancer Staging Manual, 8th edition (Amin et al., Springer 2017)
Practice EENT questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.